[1]
“PD-1 and PDL-1 Immune Checkpoint Inhibitors: Emerging Hope for the Future of Lung Cancer Immunotherapy”, Faculty of Medicine, Tadulako University, P-ISSN: 2407-8441 and e-ISSN 2502-0749, vol. 11, no. 3, pp. 445–454, Jul. 2025, doi: 10.22487/htj.v11i3.1723.